Harold E. Varmus, president and CEO of Memorial Sloan-Kettering Cancer Center, delivers the keynote speech.
Also at the hearing, NIH director
Harold E. Varmus expressed concern with the proposed bills, arguing that "the discussion is actually running ahead of the science" because the ability to clone humans is still remote.
Gene therapy holds great promise, but it won't be realized until the field gets back to good basic science, a special advisory panel told
Harold E. Varmus, director of the National Institutes of Health in Bethesda, Md., at a meeting Dec.
Harold E. Varmus, president of the Memorial Sloan-Kettering Cancer Center in New York, will deliver the address at 1 p.m.